LACHELLE DROLLMAN: Open Payments
NPI 1891091401 · FEDERAL WAY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,182 in 63 payments from 24 companies in 2025. Trend: 2023 $1,192 · 2024 $1,647 · 2025 $2,182
Food & beverage: $1,998Education: $184
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $393 |
| Janssen Biotech, Inc. | 9 | $290 |
| Dendreon Pharmaceuticals LLC | 6 | $198 |
| Astellas Pharma US Inc | 4 | $195 |
| ABBVIE INC. | 3 | $107 |
| Merck Sharp & Dohme LLC | 3 | $93 |
| UROGEN PHARMA, INC. | 3 | $92 |
| Verity Pharmaceuticals Inc. | 2 | $83 |
| Endo USA, Inc. | 3 | $80 |
| BLUEWIND MEDICAL | 1 | $73 |
Products named: ERLEADA, GEMTESA, PROVENGE, ORGOVYX, Xtandi, BOTOX, LYNPARZA, Trelstar.
Industry payments across WA — which companies pay providers there.
